These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23558130)

  • 1. [A case of pancreatic neuroendocrine tumor with excessively-advanced liver metastasis treated with S-1/GEM combination chemotherapy plus the long-acting somatostatin analogue octreotide].
    Yoshida Y; Sugawara N; Minami T; Iwata N; Ikeda K; Endoh T; Sasano H
    Nihon Shokakibyo Gakkai Zasshi; 2013 Apr; 110(4):660-8. PubMed ID: 23558130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A long-term survival case of unresectable malignant pancreatic endocrine tumor successfully treated with systemic chemotherapy].
    Masuda T; Kuwahara A
    Gan To Kagaku Ryoho; 2008 May; 35(5):833-5. PubMed ID: 18487924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two Cases of Liver Metastasis from Pancreatic Cancer with a Complete Response Owing to Chemotherapy].
    Suda H; Omori K; Suematsu Y; Hiratsuka M; Takahashi M; Saito H; Ishibashi Y; Morita A; Wakabayashi K; Ito Y
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2388-90. PubMed ID: 26805373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poorly differentiated neuroendocrine carcinoma of the pancreas responsive to combination therapy with gemcitabine and S-1.
    Yamamoto M; Miyagawa K; Hiura M; Taguchi M; Kihara Y; Abe S; Shimajiri S; Harada M
    Intern Med; 2012; 51(7):727-32. PubMed ID: 22466828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy].
    Hoshino H; Takeda Y; Nagano H; Nakamori S; Kobayashi S; Eguchi H; Marubashi S; Tanemura M; Kitagawa T; Umeshita K; Monden M; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2419-21. PubMed ID: 20037442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of liver metastasis of pancreatic cancer that was resistant to S-1 and gemcitabine successfully treated by 5-FU and cisplatin hepatic arterial infusion].
    Iwauchi T; Amano R; Ohira G; Nakamoto K; Doi Y; Yamada N; Ohira M; Hirakawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2373-5. PubMed ID: 21224577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.
    Cao C; Kuang M; Xu W; Zhang X; Chen J; Tang C
    Jpn J Clin Oncol; 2015 Dec; 45(12):1122-30. PubMed ID: 26518328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [S-1+gemcitabine (GEM) therapy effective in a case of pancreatic body cancer with multiple liver metastasis].
    Fukui H; Kou C; Matsumoto T; Matsumoto M
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1775-8. PubMed ID: 20841945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer.
    Yamauchi J; Kanai M; Matsumoto S; Nishimura T; Yazumi S; Kami K; Kawaguchi Y; Yasuda H; Kitano T; Misawa A; Ishiguro H; Yoshikawa K; Yanagihara K; Fukushima M; Doi R; Chiba T
    Pancreas; 2008 Apr; 36(3):327-8. PubMed ID: 18362852
    [No Abstract]   [Full Text] [Related]  

  • 10. [A resected case of effective treatment with S-1/gemcitabine and Paclitaxel combination chemotherapy for advanced pancreatic cancer with peritoneal and liver metastases].
    Kimura H; Fushida S; Mukawa A
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1191-4. PubMed ID: 19620816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case report of hepatic arterial infusion chemotherapy and RFA for liver metastasis from pancreatic cancer].
    Nakayama A; Tajima H; Kitagawa H; Shoji M; Nakanuma S; Makino I; Hayashi H; Nakagawara H; Miyashita T; Takamura H; Ohta T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2205-7. PubMed ID: 25731471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of pancreatic acinar cell carcinoma with a giant liver metastasis successfully treated with combination of gemcitabine and peroral S-1].
    Nishimizu T; Minemura M; Kajiura S; Tokimitsu Y; Itaya Y; Yamawaki H; Kawai K; Tajiri K; Nakayama Y; Hosokawa A; Takahara T; Yasumura S; Shimizu S; Fukuoka J; Ishizawa S; Sawasaki T; Yanagisawa A; Sugiyama T
    Gan To Kagaku Ryoho; 2011 Feb; 38(2):309-12. PubMed ID: 21368502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gemcitabine plus S-1 combination therapy (GS therapy) for pancreatic cancer patients with high-grade hepatic metastasis].
    Matsumoto T; Takeji S; Asagi A; Kajiwara T; Nishina T; Hori S; Ikeda Y; Nadano S; Iguchi H
    Nihon Shokakibyo Gakkai Zasshi; 2011 Dec; 108(12):2003-9. PubMed ID: 22139487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of advanced pancreatic cancer responding well to S-1/gemcitabine combination therapy after gemcitabine therapy].
    Kuji M; Yamamoto Y; Tani C; Kenno S; Kobayashi T
    Gan To Kagaku Ryoho; 2011 May; 38(5):853-5. PubMed ID: 21566453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjuvant gemcitabine plus S-1 chemotherapy for pancreatic cancer after surgical resection - outcomes and future perspectives].
    Murakami Y; Uemura K; Sudo T
    Nihon Shokakibyo Gakkai Zasshi; 2011 Oct; 108(10):1661-9. PubMed ID: 21971141
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effective multidisciplinary therapy mainly using S-1+ gemcitabine (GEM) for a case of pancreatic body cancer with multiple liver metastases].
    Fukui H; Kou C; Fujioka M
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1727-31. PubMed ID: 23152029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two cases of pancreatic cancer with multiple liver metastases treated with radical treatment after successful treatment with gemcitabine plus S-1 therapy].
    Sato Y; Tsuchiya Y; Aizawa M; Nomura T; Nashimoto A
    Gan To Kagaku Ryoho; 2014 Sep; 41(9):1151-4. PubMed ID: 25248901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical benefit of full-dose gemcitabine for advanced pancreatic cancer refractory to S-1+gemcitabine].
    Hachisuka H; Takahashi M; Kushima A; Nakamoto T; Takahashi K; Iwamura Y; Wakata M; Nagano K; Nakajima T; Nunomura M; Araki K
    Gan To Kagaku Ryoho; 2013 May; 40(5):639-42. PubMed ID: 23863590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Questions on "gemcitabine plus S-1 combination therapy (G-S therapy) for pancreatic cancer with accentuated hepatic metastasis" (by Matsumoto, T. et al) published on Japanese Journal of Gastro-enterology Vol. 108, N0. 12].
    Haruta J
    Nihon Shokakibyo Gakkai Zasshi; 2013 Jan; 110(1):112-3. PubMed ID: 23303237
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma.
    Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Nakagawa N; Sueda T
    J Surg Oncol; 2012 Aug; 106(2):174-80. PubMed ID: 22331838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.